Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi

#InsulinPrices | #HealthcareReform | #AffordableInsulin | #DiabetesCare | #Minnesota |  #InsulinCrisis | #DrugPricing | #PatientAdvocacy | #PharmaSettlement
Read more: